Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study to Determine Safety, Tolerability and Bioactivity of Nexvax2 in HLA DQ2+ Volunteers With Coeliac Disease Following a Long-term, Strict Gluten-free Diet

NCT00879749 is registered in ClinicalTrials.gov with Nexpep Pty Ltd as lead sponsor.

NCT NCT00879749
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00879749 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study to Determine Safety, Tolerability and Bioactivity of Nexvax2 in HLA DQ2+ Volunteers With Coeliac Disease Following a Long-term, Strict Gluten-free Diet
Lead sponsor
Nexpep Pty Ltd
Phase
Phase 1
Overall status
Completed
Start date
April 30, 2009
Completion date
June 30, 2010
Enrollment
34 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

celiac disease, coeliac disease